FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Care and Connection That Matter

Access to care, trusted guidance, and meaningful programs that support individuals and families—every step of the way.

MDA Engage Community Education Seminar: San Francisco

Saturday, April 6, 2019
Registration & Breakfast: 9:00-10:00am
Event: 10:00am-4:00pm (lunch included)
Social Hour: 4:00-5:00pm

Event Chair: Dr. Catherine Lomen-Hoerth, Director, ALS Center at University of California, San Francisco

Event Location:
Google Community Space
188 The Embarcadero
San Francisco, CA 94105

Registration has Closed

 

Thank you to our supporter

Genentech

For questions reach out to: mdaengage@mdausa.org | 1-833-ASK-MDA1 (1-833-275-6321)